Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT)

NCT03299244 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

637

Enrollment

INDUSTRY

Sponsor class

Conditions

Secondary Hyperparathyroidism
Chronic Kidney Disease

Interventions

DRUG: Etelcalcetide
DRUG: Cinacalcet

Sponsor

Amgen